|
KRCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.14028794687238E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01639996419323E-09 |
| Normal-vs-Stage2 |
1.17330000048987E-07 |
| Normal-vs-Stage3 |
6.03850303093623E-13 |
| Normal-vs-Stage4 |
4.55357973550008E-12 |
| Stage1-vs-Stage2 |
2.447800E-01 |
| Stage1-vs-Stage3 |
1.301840E-03 |
| Stage1-vs-Stage4 |
2.181200E-03 |
| Stage2-vs-Stage3 |
2.838000E-01 |
| Stage2-vs-Stage4 |
1.524430E-01 |
| Stage3-vs-Stage4 |
6.099800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.94428933958579E-12 |
| Normal-vs-AfricanAmerican |
1.50332999999669E-05 |
| Normal-vs-Asian |
6.12770000296692E-08 |
| Caucasian-vs-AfricanAmerican |
6.535800E-01 |
| Caucasian-vs-Asian |
7.844200E-01 |
| AfricanAmerican-vs-Asian |
5.497600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.65729701868167E-11 |
| Normal-vs-Female |
5.09114972402358E-12 |
| Male-vs-Female |
8.187600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.91559995327873E-09 |
| Normal-vs-Age(41-60Yrs) |
8.84400330747326E-11 |
| Normal-vs-Age(61-80Yrs) |
1.72639680329212E-12 |
| Normal-vs-Age(81-100Yrs) |
4.23750000000389E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.995200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.723130E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.301050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.166200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.926400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.521400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.476300E-02 |
| Classical-VS-Follicular |
7.570000E-01 |
| Classical-VS-Other |
3.811200E-01 |
| Classical-VS-Normal |
3.22699644783597E-11 |
| Tall-VS-Follicular |
6.916100E-02 |
| Tall-VS-Other |
1.837430E-01 |
| Tall-VS-Normal |
2.10660000554697E-09 |
| Follicular-VS-Other |
4.148800E-01 |
| Follicular-VS-Normal |
1.31720000018376E-07 |
| Other-VS-Normal |
1.075160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92589952266553E-10 |
| Normal-vs-N1 |
9.7367000018167E-09 |
| N0-vs-N1 |
5.975000E-01 |
|
|
